Table:
begin	end	state
1	11	cytoplasmic
12	32	transmembrane
33	48	non-cytoplasmic
49	73	transmembrane
74	79	cytoplasmic
80	99	transmembrane
100	104	non-cytoplasmic
105	126	transmembrane
127	137	cytoplasmic
138	161	transmembrane
162	171	non-cytoplasmic
172	194	transmembrane
195	240	cytoplasmic
241	262	transmembrane
263	273	non-cytoplasmic
274	294	transmembrane
295	304	cytoplasmic
305	324	transmembrane
325	329	non-cytoplasmic
330	350	transmembrane
351	356	cytoplasmic
357	380	transmembrane
381	394	non-cytoplasmic
395	415	transmembrane
416	430	cytoplasmic

Input:
>WP_050465826.1 NCBI__GCF_001189915.1:WP_050465826.1
MNEDQLYKRVTLRLIPFLVLLYLIAYIDRSILGFAKLYMNVDVGISDAAYGFGAGLFFLG
YILFEVPSNLILVKVGARRWFARIILTWGAITVAMALIQGPTSFYILRFLLGAAEAGFYP
GVLYYLTLWYPKQRRGRIYGYFFFAQPLAPLVGGPLAGALLGMNGMLGVHGWQWVFILCG
LPAVLLALPTLKLLPEKPQDAKWLTPQEAHWLTSGIERGSAGIAAATKSHSPLQALKNPR
VLLLAFAYVPIPLAIYGLSLWLPTLVKAFNASDFTTGVLSAVPFLFGVIGLLIVPRSSDK
RNERYGHIIVCTLLAAAGLIGAALSHSLALQLSFLCMTGFGMYSASAVLWTLPSQFLVGT
GAAAGLAVINSIGNLGGYLGPFGIGLIKEYTGSLAYGLYFLAASLVLVIVLVLILRAMGE
VDKGSAGTSR

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server